KAILEY HATFIELD: Open Payments
NPI 1629441746 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 44 payments from 13 companies in 2025. Trend: 2023 $632 · 2024 $455 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $154 |
| Eisai Inc. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $104 |
| Abbott Laboratories | 4 | $88 |
| ABBVIE INC. | 3 | $68 |
| Lundbeck LLC | 4 | $58 |
| Lilly USA, LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
Products named: XIFAXAN, Leqembi, Kerendia, REXULTI, FREESTYLE LIBRE, QULIPTA, AIRSUPRA, Veozah.
Industry payments across TX — which companies pay providers there.
